daunorubicin has been researched along with Acute Autoimmune Neuropathy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berenguer-Potenciano, M; Camacho-Salas, A; Nunez-Enamorado, N; Perez-Alonso, V; Simon-De Las Heras, R; Villora-Morcillo, N | 1 |
| Campos, T; Franco-Macías, E; Gómez-Aranda, F; González Pérez, P; Montes-Latorre, E; Serrano-Pozo, A | 1 |
| Bamborschke, S; Diehl, V; Hegener, P; Re, D; Schwenk, A; Tesch, H | 1 |
3 other study(ies) available for daunorubicin and Acute Autoimmune Neuropathy
| Article | Year |
|---|---|
[Therapeutic response to pyridoxine and pyridostigmine in a paediatric case of severe peripheral and cranial polyneuropathy due to vincristine].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blepharoptosis; Cranial Nerve Diseases; Daunorubicin; Diagnosis, Differential; Esotropia; Female; Guillain-Barre Syndrome; Humans; Imatinib Mesylate; Infant; Peripheral Nervous System Diseases; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyridostigmine Bromide; Pyridoxine; Quadriplegia; Vincristine | 2015 |
Vincristine-induced acute neurotoxicity versus Guillain-Barré syndrome: a diagnostic dilemma.
Topics: Action Potentials; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Dexamethasone; Diagnosis, Differential; Erectile Dysfunction; Fatal Outcome; Guillain-Barre Syndrome; Humans; Hydrocortisone; Male; Methotrexate; Paraparesis; Paresthesia; Polyradiculoneuropathy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Urination Disorders; Vincristine | 2007 |
Guillain-Barré syndrome in a patient with non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy, Needle; Daunorubicin; Electromyography; Female; Follow-Up Studies; Guillain-Barre Syndrome; Humans; Immunoglobulins, Intravenous; Lymphoma, Non-Hodgkin; Prednisolone; Treatment Outcome; Vincristine | 2000 |